Universal screening for meticillin-resistant Staphylococcus aureus in acute care: risk factors and outcome from a multicentre study

J. S. Reilly, S. Stewart, P. Christie, G. M. Allardice, T. Stari, A. Matheson, R. Masterton, I. M. Gould, C. Williams

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

A Health Technology Assessment (HTA) model on effectiveness of meticillin-resistant Staphylococcus aureus (MRSA) screening in Scotland suggested that universal screening using chromogenic agar was the preferred option in terms of effectiveness and cost. To test the model’s validity through a one-year pilot-study. A large one-year prospective cohort study of MRSA screening was carried out in six acute hospitals in NHS Scotland, incorporating 81,438 admissions. Outcomes (MRSA colonization and infection rates) were subjected to multivariable analyses, and trends before and after implementation of screening were compared. The initial colonization prevalence of 5.5% decreased to 3.5% by month 12 of the study (P < 0.0001). Colonization was associated with the number of admissions per patient, specialty of admission, age, and source of admission (home, other hospital or care home). Around 2% of all admissions with no prior history of MRSA infection or colonization tested positive. Those who were screen positive on admission and not previously known positive were 12 times more likely than those who screened negative to develop infection, increasing to 18 times if they were both screen positive and previously known positive. MRSA infections (7.5 per 1000 inpatient-days overall) also reduced significantly over the study year (P = 0.0209). The risk factors identified for colonization and infection indicate that a universal clinical risk assessment may have a role in MRSA screening.
LanguageEnglish
Pages31-35
Number of pages5
JournalJournal of Hospital Infection
Volume80
Issue number1
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Methicillin
Multicenter Studies
Staphylococcus aureus
Infection
Scotland
Biomedical Technology Assessment
Patient Admission
Home Care Services
Agar
Cost-Benefit Analysis
Inpatients
Cohort Studies
Prospective Studies

Keywords

  • screening
  • hospital admissions
  • MRSA
  • meticillin-resistant
  • infection
  • surveillance
  • prevalence
  • staphylococcus aureus
  • surgery
  • chromogenic agar

Cite this

Reilly, J. S. ; Stewart, S. ; Christie, P. ; Allardice, G. M. ; Stari, T. ; Matheson, A. ; Masterton, R. ; Gould, I. M. ; Williams, C. / Universal screening for meticillin-resistant Staphylococcus aureus in acute care : risk factors and outcome from a multicentre study. In: Journal of Hospital Infection. 2012 ; Vol. 80, No. 1. pp. 31-35.
@article{271ee0ecda6d4b0e8a5b78734b09f67b,
title = "Universal screening for meticillin-resistant Staphylococcus aureus in acute care: risk factors and outcome from a multicentre study",
abstract = "A Health Technology Assessment (HTA) model on effectiveness of meticillin-resistant Staphylococcus aureus (MRSA) screening in Scotland suggested that universal screening using chromogenic agar was the preferred option in terms of effectiveness and cost. To test the model’s validity through a one-year pilot-study. A large one-year prospective cohort study of MRSA screening was carried out in six acute hospitals in NHS Scotland, incorporating 81,438 admissions. Outcomes (MRSA colonization and infection rates) were subjected to multivariable analyses, and trends before and after implementation of screening were compared. The initial colonization prevalence of 5.5{\%} decreased to 3.5{\%} by month 12 of the study (P < 0.0001). Colonization was associated with the number of admissions per patient, specialty of admission, age, and source of admission (home, other hospital or care home). Around 2{\%} of all admissions with no prior history of MRSA infection or colonization tested positive. Those who were screen positive on admission and not previously known positive were 12 times more likely than those who screened negative to develop infection, increasing to 18 times if they were both screen positive and previously known positive. MRSA infections (7.5 per 1000 inpatient-days overall) also reduced significantly over the study year (P = 0.0209). The risk factors identified for colonization and infection indicate that a universal clinical risk assessment may have a role in MRSA screening.",
keywords = "screening, hospital admissions, MRSA, meticillin-resistant, infection, surveillance, prevalence, staphylococcus aureus, surgery, chromogenic agar",
author = "Reilly, {J. S.} and S. Stewart and P. Christie and Allardice, {G. M.} and T. Stari and A. Matheson and R. Masterton and Gould, {I. M.} and C. Williams",
year = "2012",
month = "1",
doi = "10.1016/j.jhin.2011.09.008",
language = "English",
volume = "80",
pages = "31--35",
journal = "Journal of Hospital Infection",
issn = "0195-6701",
number = "1",

}

Reilly, JS, Stewart, S, Christie, P, Allardice, GM, Stari, T, Matheson, A, Masterton, R, Gould, IM & Williams, C 2012, 'Universal screening for meticillin-resistant Staphylococcus aureus in acute care: risk factors and outcome from a multicentre study' Journal of Hospital Infection, vol. 80, no. 1, pp. 31-35. https://doi.org/10.1016/j.jhin.2011.09.008

Universal screening for meticillin-resistant Staphylococcus aureus in acute care : risk factors and outcome from a multicentre study. / Reilly, J. S.; Stewart, S.; Christie, P.; Allardice, G. M.; Stari, T.; Matheson, A.; Masterton, R.; Gould, I. M.; Williams, C.

In: Journal of Hospital Infection, Vol. 80, No. 1, 01.2012, p. 31-35.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Universal screening for meticillin-resistant Staphylococcus aureus in acute care

T2 - Journal of Hospital Infection

AU - Reilly, J. S.

AU - Stewart, S.

AU - Christie, P.

AU - Allardice, G. M.

AU - Stari, T.

AU - Matheson, A.

AU - Masterton, R.

AU - Gould, I. M.

AU - Williams, C.

PY - 2012/1

Y1 - 2012/1

N2 - A Health Technology Assessment (HTA) model on effectiveness of meticillin-resistant Staphylococcus aureus (MRSA) screening in Scotland suggested that universal screening using chromogenic agar was the preferred option in terms of effectiveness and cost. To test the model’s validity through a one-year pilot-study. A large one-year prospective cohort study of MRSA screening was carried out in six acute hospitals in NHS Scotland, incorporating 81,438 admissions. Outcomes (MRSA colonization and infection rates) were subjected to multivariable analyses, and trends before and after implementation of screening were compared. The initial colonization prevalence of 5.5% decreased to 3.5% by month 12 of the study (P < 0.0001). Colonization was associated with the number of admissions per patient, specialty of admission, age, and source of admission (home, other hospital or care home). Around 2% of all admissions with no prior history of MRSA infection or colonization tested positive. Those who were screen positive on admission and not previously known positive were 12 times more likely than those who screened negative to develop infection, increasing to 18 times if they were both screen positive and previously known positive. MRSA infections (7.5 per 1000 inpatient-days overall) also reduced significantly over the study year (P = 0.0209). The risk factors identified for colonization and infection indicate that a universal clinical risk assessment may have a role in MRSA screening.

AB - A Health Technology Assessment (HTA) model on effectiveness of meticillin-resistant Staphylococcus aureus (MRSA) screening in Scotland suggested that universal screening using chromogenic agar was the preferred option in terms of effectiveness and cost. To test the model’s validity through a one-year pilot-study. A large one-year prospective cohort study of MRSA screening was carried out in six acute hospitals in NHS Scotland, incorporating 81,438 admissions. Outcomes (MRSA colonization and infection rates) were subjected to multivariable analyses, and trends before and after implementation of screening were compared. The initial colonization prevalence of 5.5% decreased to 3.5% by month 12 of the study (P < 0.0001). Colonization was associated with the number of admissions per patient, specialty of admission, age, and source of admission (home, other hospital or care home). Around 2% of all admissions with no prior history of MRSA infection or colonization tested positive. Those who were screen positive on admission and not previously known positive were 12 times more likely than those who screened negative to develop infection, increasing to 18 times if they were both screen positive and previously known positive. MRSA infections (7.5 per 1000 inpatient-days overall) also reduced significantly over the study year (P = 0.0209). The risk factors identified for colonization and infection indicate that a universal clinical risk assessment may have a role in MRSA screening.

KW - screening

KW - hospital admissions

KW - MRSA

KW - meticillin-resistant

KW - infection

KW - surveillance

KW - prevalence

KW - staphylococcus aureus

KW - surgery

KW - chromogenic agar

UR - http://www.scopus.com/inward/record.url?scp=84455208138&partnerID=8YFLogxK

U2 - 10.1016/j.jhin.2011.09.008

DO - 10.1016/j.jhin.2011.09.008

M3 - Article

VL - 80

SP - 31

EP - 35

JO - Journal of Hospital Infection

JF - Journal of Hospital Infection

SN - 0195-6701

IS - 1

ER -